Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARa and T- and B-cell targeting
Resources
2 resources available
-
PFOA-17 data for scihub.xls
APPLICATION/VND.MS-EXCEL -
PFOA-21 phenotype support data sciehub.xls
APPLICATION/VND.MS-EXCEL
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| bureauCode |
[ "020:00" ] |
| contactPoint |
{ "fn": "Robert Luebke", "hasEmail": "mailto:luebke.robert@epa.gov" } |
| description | Dosing information, body weights during exposure and immune system endpoints. This dataset is associated with the following publication: DeWitt, J., W. Williams , J. Creech, and R. Luebke. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARalpha and T- and B-cell targeting. JOURNAL OF IMMUNOTOXICOLOGY. Taylor & Francis, Inc., Philadelphia, PA, USA, 13(1): 38-45, (2016). |
| distribution |
[ { "title": "PFOA-17 data for scihub.xls", "mediaType": "application/vnd.ms-excel", "downloadURL": "https://pasteur.epa.gov/uploads/75/PFOA-17%20data%20for%20scihub.xls" }, { "title": "PFOA-21 phenotype support data sciehub.xls", "mediaType": "application/vnd.ms-excel", "downloadURL": "https://pasteur.epa.gov/uploads/75/PFOA-21%20phenotype%20support%20data%20sciehub.xls" } ] |
| identifier | A-z61s-75 |
| keyword |
[ "immunotoxicity", "perfluorooctanoic acid", "peroxisome proliferator activated receptor alpha" ] |
| license | https://pasteur.epa.gov/license/sciencehub-license.html |
| modified | 2016-05-23 |
| programCode |
[ "020:000" ] |
| publisher |
{ "name": "U.S. EPA Office of Research and Development (ORD)", "subOrganizationOf": { "name": "U.S. Environmental Protection Agency", "subOrganizationOf": { "name": "U.S. Government" } } } |
| references |
null
|
| rights |
null
|
| title | Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARa and T- and B-cell targeting |